Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1126)
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$580.03
Total Value
$23.20K
Shares Held After
18,876
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$579.04
Total Value
$231.62K
Shares Held After
18,916
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
601
Price
$577.93
Total Value
$347.33K
Shares Held After
19,316
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,603
Price
$577.01
Total Value
$924.95K
Shares Held After
19,917
% of Holdings
7.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,354
Price
$575.96
Total Value
$779.84K
Shares Held After
21,520
% of Holdings
5.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,457
Price
$575.06
Total Value
$837.86K
Shares Held After
22,874
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,860
Price
$574.00
Total Value
$1.07M
Shares Held After
24,331
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,210
Price
$572.96
Total Value
$693.28K
Shares Held After
26,191
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,154
Price
$571.76
Total Value
$659.81K
Shares Held After
27,401
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
281
Price
$571.14
Total Value
$160.49K
Shares Held After
28,555
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$569.61
Total Value
$22.78K
Shares Held After
28,836
% of Holdings
0.1%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
33,171
Price
$6.41
Total Value
$212.76K
Shares Held After
49,849
% of Holdings
40.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
3,338
Price
$14.08
Total Value
$47.00K
Shares Held After
421,174
% of Holdings
0.8%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
15,722
Price
$12.95
Total Value
$203.60K
Shares Held After
424,512
% of Holdings
3.6%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
21,433
Price
$40.12
Total Value
$859.88K
Shares Held After
1,495,234
% of Holdings
1.4%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
23,821
Price
$40.14
Total Value
$956.25K
Shares Held After
411,855
% of Holdings
5.5%
Annexon, Inc. (ANNX)
Carson William H. — Director
Shares
8,000
Price
$6.20
Total Value
$49.60K
Shares Held After
70,405
% of Holdings
11.4%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
500
Price
$34.98
Total Value
$17.49K
Shares Held After
286,016
% of Holdings
0.2%
Whitehawk Therapeutics, Inc. (WHWK)
BALL BRYAN — Chief Technical Operations Officer and SVP, Manufacturing Operations
Shares
6,596
Price
$3.43
Total Value
$22.62K
Shares Held After
515,955
% of Holdings
1.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
400
Price
$13.48
Total Value
$5.39K
Shares Held After
425,512
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
18,660
Price
$12.75
Total Value
$237.91K
Shares Held After
425,912
% of Holdings
4.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
20,000
Price
$74.60
Total Value
$1.49M
Shares Held After
4,398,447
% of Holdings
0.5%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
20,000
Price
$74.60
Total Value
$1.49M
Shares Held After
595,686
% of Holdings
3.2%
Taysha Gene Therapies, Inc. (TSHA)
Nagendran Sukumar — Director
Shares
200,000
Price
$4.46
Total Value
$892.00K
Shares Held After
1,136,410
% of Holdings
15.0%
Ginkgo Bioworks Holdings, Inc. (DNA)
Canton Barry — 10% Owner
Shares
124,727
Price
$6.43
Total Value
$802.49K
Shares Held After
436,422
% of Holdings
22.2%
Ginkgo Bioworks Holdings, Inc. (DNA)
Shetty Reshma P. — Director
Shares
124,727
Price
$6.43
Total Value
$802.49K
Shares Held After
436,422
% of Holdings
22.2%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
3,125
Price
$2.56
Total Value
$8.01K
Shares Held After
29,375
% of Holdings
9.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$573.01
Total Value
$22.92K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
459
Price
$571.68
Total Value
$262.40K
Shares Held After
40,553
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,215
Price
$570.88
Total Value
$693.62K
Shares Held After
41,012
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,056
Price
$569.97
Total Value
$1.17M
Shares Held After
42,227
% of Holdings
4.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,183
Price
$568.97
Total Value
$1.81M
Shares Held After
44,283
% of Holdings
6.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,105
Price
$568.00
Total Value
$1.20M
Shares Held After
47,466
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
442
Price
$567.24
Total Value
$250.72K
Shares Held After
49,571
% of Holdings
0.9%
Xencor Inc (XNCR)
Cornelissen Bart Jan — SR. VICE PRESIDENT & CFO
Shares
3,499
Price
$12.29
Total Value
$42.99K
Shares Held After
75,898
% of Holdings
4.4%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
2,324,072
Price
$1.48
Total Value
$3.44M
Shares Held After
8,324,072
% of Holdings
27.9%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
2,324,072
Price
$1.48
Total Value
$3.44M
Shares Held After
8,324,072
% of Holdings
27.9%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
828
Price
$15.75
Total Value
$13.04K
Shares Held After
3,935,608
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,000
Price
$87.35
Total Value
$174.70K
Shares Held After
51,542
% of Holdings
3.7%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.89
Total Value
$48.95K
Shares Held After
3,042,000
% of Holdings
0.3%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,170
Price
$27.38
Total Value
$59.41K
Shares Held After
76,140
% of Holdings
2.8%
Whitehawk Therapeutics, Inc. (WHWK)
BALL BRYAN — Chief Technical Operations Officer and SVP, Manufacturing Operations
Shares
50,000
Price
$3.57
Total Value
$178.50K
Shares Held After
522,551
% of Holdings
8.7%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
2,100
Price
$14.44
Total Value
$30.32K
Shares Held After
429,850
% of Holdings
0.5%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
16,960
Price
$13.79
Total Value
$233.88K
Shares Held After
431,950
% of Holdings
3.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,800
Price
$75.53
Total Value
$589.12K
Shares Held After
4,418,447
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,128
Price
$74.57
Total Value
$382.38K
Shares Held After
4,426,247
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,072
Price
$73.64
Total Value
$520.80K
Shares Held After
4,431,375
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,500
Price
$75.55
Total Value
$566.66K
Shares Held After
615,686
% of Holdings
1.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,300
Price
$74.60
Total Value
$395.40K
Shares Held After
623,186
% of Holdings
0.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,200
Price
$73.64
Total Value
$530.24K
Shares Held After
628,486
% of Holdings
1.1%
Showing 351–400 of 1126 transactions (page 8 of 23)